Search Results
Independent validation of the HER2DX genomic test in HER2-positive breast cancer
HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer
HER2DX and pCR in HER2-positive breast cancer: a combined analysis of 4 neoadjuvant studies
HER2DX risk-score in early-stage HER2-positive breast cancer
Early Breast Cancer-Perceptorship Program
The OncoAlert Colloquium Day 3 (Breast Cancer)
Validação do Residual Cancer Burden score em um hospital terciário no Brasil
